2021
DOI: 10.1136/bmjdrc-2021-002264
|View full text |Cite
|
Sign up to set email alerts
|

Shape of the OGTT glucose response curve: relationship with β-cell function and differences by sex, race, and BMI in adults with early type 2 diabetes treated with metformin

Abstract: IntroductionThe shape of the glucose curve during an oral glucose tolerance test (OGTT) reflects β-cell function in populations without diabetes but has not been as well studied in those with diabetes. A monophasic shape has been associated with higher risk of diabetes, while a biphasic pattern has been associated with lower risk. We sought to determine if phenotypic or metabolic characteristics were associated with glucose response curve shape in adults with type 2 diabetes treated with metformin alone.Resear… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 22 publications
0
13
1
Order By: Relevance
“…The oral glucose tolerance test (OGTT) is a glucose stress test that reveals the function of pancreatic islets and the body’s ability to regulate blood sugar ( 26 ). No significant differences were found in the areas under the blood glucose and insulin curves between groups or time points ( Fig.…”
Section: Resultsmentioning
confidence: 99%
“…The oral glucose tolerance test (OGTT) is a glucose stress test that reveals the function of pancreatic islets and the body’s ability to regulate blood sugar ( 26 ). No significant differences were found in the areas under the blood glucose and insulin curves between groups or time points ( Fig.…”
Section: Resultsmentioning
confidence: 99%
“…This result may also have direct relevance to the findings in the paper by Utzschneider et al where they made an association between plasma glucose profile shape and beta cell function in newly diagnosed T2D patients. ( Utzschneider et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…The ∆AUC insulin and ∆AUC glucose for each OST were obtained by subtracting the AUC for the total response by the corresponding fasting baseline AUC, which was obtained by taking the fasting values for plasma insulin or glucose × 180 min 15 . The ratio of ∆AUC insulin /∆AUC glucose was used as an index to reflect insulin response to the concomitant plasma glucose concentration over the entire OST (ie, an index of β‐cell responsiveness to glucose) 2,16‐18 …”
Section: Methodsmentioning
confidence: 99%